CCN2 and cancer: Tafazzin is a co-activator of the Hippo pathways, which is responsible for the transcription of multiple tumorigenesis genes (such as cyclin D1 and CCN2 (connective tissue growth factor)); thus, they are involved in cancer development and progression [57].